Breakthrough oral drug could save lives from deadly fungal infections
Disease control
Ongoing
This study compares a new oral medication called olorofim against the current standard intravenous treatment for invasive aspergillosis, a serious fungal infection that often affects people with weakened immune systems. The trial focuses on patients who cannot use standard antifu…
Phase: PHASE3 • Sponsor: F2G Biotech GmbH • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC